markusathome
@markusathome.bsky.social
www.youtube.com/@MarkusAtHome
Anticoagulation in CKD & A Fib - SACK - Dr. Marie Evans, Dr. Anne-Laure Faucon (Stockholm, Sweden)
youtu.be/l1XhFnr-HiM?...
youtu.be/l1XhFnr-HiM?...
Anticoagulation in CKD & A Fib - SACK - Dr. Marie Evans, Dr. Anne-Laure Faucon (Stockholm, Sweden)
YouTube video by MARKUS at HOMe
youtu.be
February 1, 2026 at 5:36 PM
Anticoagulation in CKD & A Fib - SACK - Dr. Marie Evans, Dr. Anne-Laure Faucon (Stockholm, Sweden)
youtu.be/l1XhFnr-HiM?...
youtu.be/l1XhFnr-HiM?...
Flu / RSV Vaccination: DANFLU-2 / DAN-RSV / VHA - Prof. K. Bajema, Prof. T. Biering-Sørensen
youtu.be/jZPnlwb3dvU?...
youtu.be/jZPnlwb3dvU?...
Flu / RSV Vaccination: DANFLU-2 / DAN-RSV / VHA - Prof. K. Bajema, Prof. T. Biering-Sørensen
YouTube video by MARKUS at HOMe
youtu.be
January 23, 2026 at 6:24 PM
Flu / RSV Vaccination: DANFLU-2 / DAN-RSV / VHA - Prof. K. Bajema, Prof. T. Biering-Sørensen
youtu.be/jZPnlwb3dvU?...
youtu.be/jZPnlwb3dvU?...
We are very pleased to welcome him back:
Lipidologie für Nichtlipidologen I: LDL-C - Prof. Dr. Ulrich Laufs (Leipzig)
youtu.be/5rJv1ncCick?...
Lipidologie für Nichtlipidologen I: LDL-C - Prof. Dr. Ulrich Laufs (Leipzig)
youtu.be/5rJv1ncCick?...
Lipidologie für Nichtlipidologen I: LDL-C - Prof. Dr. Ulrich Laufs (Leipzig)
YouTube video by MARKUS at HOMe
youtu.be
January 18, 2026 at 5:44 PM
We are very pleased to welcome him back:
Lipidologie für Nichtlipidologen I: LDL-C - Prof. Dr. Ulrich Laufs (Leipzig)
youtu.be/5rJv1ncCick?...
Lipidologie für Nichtlipidologen I: LDL-C - Prof. Dr. Ulrich Laufs (Leipzig)
youtu.be/5rJv1ncCick?...
Finally, the time has come: Nephrology / Hypertension 2025 II
...simultaneously with our 6000th follower!
Who will be on the winner's podium?
youtu.be/W_1GjTPD29E?...
...simultaneously with our 6000th follower!
Who will be on the winner's podium?
youtu.be/W_1GjTPD29E?...
Nephrologie / Hypertensiologie 2025 II
YouTube video by MARKUS at HOMe
youtu.be
January 9, 2026 at 8:28 PM
Finally, the time has come: Nephrology / Hypertension 2025 II
...simultaneously with our 6000th follower!
Who will be on the winner's podium?
youtu.be/W_1GjTPD29E?...
...simultaneously with our 6000th follower!
Who will be on the winner's podium?
youtu.be/W_1GjTPD29E?...
Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a) by Drs. Nordestgaard, Ridker et al.
Very high Lp(a) levels correlated with increased 30-year risk of CV disease among healthy women.
jamanetwork.com/journals/jam...
Very high Lp(a) levels correlated with increased 30-year risk of CV disease among healthy women.
jamanetwork.com/journals/jam...
January 8, 2026 at 8:09 PM
Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a) by Drs. Nordestgaard, Ridker et al.
Very high Lp(a) levels correlated with increased 30-year risk of CV disease among healthy women.
jamanetwork.com/journals/jam...
Very high Lp(a) levels correlated with increased 30-year risk of CV disease among healthy women.
jamanetwork.com/journals/jam...
Age-Adjusted D-Dimer Cutoff Levels to Rule Out Deep Vein Thrombosis by Drs. Le Gal, Righini et al.
The age-adjusted D-dimer cutoff may safely rule out DVT and was associated with a larger number of patients in whom DVT could be effectively ruled out.
jamanetwork.com/journals/jam...
The age-adjusted D-dimer cutoff may safely rule out DVT and was associated with a larger number of patients in whom DVT could be effectively ruled out.
jamanetwork.com/journals/jam...
January 6, 2026 at 8:40 PM
Age-Adjusted D-Dimer Cutoff Levels to Rule Out Deep Vein Thrombosis by Drs. Le Gal, Righini et al.
The age-adjusted D-dimer cutoff may safely rule out DVT and was associated with a larger number of patients in whom DVT could be effectively ruled out.
jamanetwork.com/journals/jam...
The age-adjusted D-dimer cutoff may safely rule out DVT and was associated with a larger number of patients in whom DVT could be effectively ruled out.
jamanetwork.com/journals/jam...
It's that time again!
Nephrology/Hypertension – Top Studies 2025, Part 1!
youtu.be/n3aBxK013bY?...
@gunnarheine.bsky.social @mariamabutair.bsky.social @kronbichlerlab.bsky.social @marcussaemann.bsky.social @sarahelektra.bsky.social
Nephrology/Hypertension – Top Studies 2025, Part 1!
youtu.be/n3aBxK013bY?...
@gunnarheine.bsky.social @mariamabutair.bsky.social @kronbichlerlab.bsky.social @marcussaemann.bsky.social @sarahelektra.bsky.social
Nephrologie / Hypertensiologie 2025 I
YouTube video by MARKUS at HOMe
youtu.be
January 2, 2026 at 7:50 PM
It's that time again!
Nephrology/Hypertension – Top Studies 2025, Part 1!
youtu.be/n3aBxK013bY?...
@gunnarheine.bsky.social @mariamabutair.bsky.social @kronbichlerlab.bsky.social @marcussaemann.bsky.social @sarahelektra.bsky.social
Nephrology/Hypertension – Top Studies 2025, Part 1!
youtu.be/n3aBxK013bY?...
@gunnarheine.bsky.social @mariamabutair.bsky.social @kronbichlerlab.bsky.social @marcussaemann.bsky.social @sarahelektra.bsky.social
The MARKUS@HOMe editorial team wishes all colleagues a happy New Year's Eve 2025 and a happy, healthy, peaceful, and safe 2026.
We thank all our guests for their academic contributions and look forward to seeing you again in 2026!
youtu.be/hcRC-UQokhs?...
We thank all our guests for their academic contributions and look forward to seeing you again in 2026!
youtu.be/hcRC-UQokhs?...
Neujahr 2026
YouTube video by MARKUS at HOMe
youtu.be
December 31, 2025 at 5:22 PM
The MARKUS@HOMe editorial team wishes all colleagues a happy New Year's Eve 2025 and a happy, healthy, peaceful, and safe 2026.
We thank all our guests for their academic contributions and look forward to seeing you again in 2026!
youtu.be/hcRC-UQokhs?...
We thank all our guests for their academic contributions and look forward to seeing you again in 2026!
youtu.be/hcRC-UQokhs?...
Our top-rated cardiology study of 2025 (Best of cardiology: youtu.be/FAOH0tL2Cy8?...)
Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction by Drs. Bavendiek, Bauersachs et al.
www.nejm.org/doi/full/10....
Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction by Drs. Bavendiek, Bauersachs et al.
www.nejm.org/doi/full/10....
December 30, 2025 at 7:24 PM
Our top-rated cardiology study of 2025 (Best of cardiology: youtu.be/FAOH0tL2Cy8?...)
Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction by Drs. Bavendiek, Bauersachs et al.
www.nejm.org/doi/full/10....
Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction by Drs. Bavendiek, Bauersachs et al.
www.nejm.org/doi/full/10....
In our special Christmas episode, Mr. Reinhard Ernst (Wiesbaden) discusses the importance of access to abstract art in general and to abstract expressionism in painting in particular for people in Germany in 2026
youtu.be/HZPtOtj_058?...
youtu.be/HZPtOtj_058?...
Abstrakte Kunst für Alle? - Reinhard Ernst (Wiesbaden)
YouTube video by MARKUS at HOMe
youtu.be
December 26, 2025 at 7:08 PM
In our special Christmas episode, Mr. Reinhard Ernst (Wiesbaden) discusses the importance of access to abstract art in general and to abstract expressionism in painting in particular for people in Germany in 2026
youtu.be/HZPtOtj_058?...
youtu.be/HZPtOtj_058?...
The MARKUS@HOME editorial team wishes all colleagues a peaceful and blessed Christmas 2025.
Thank you for your interest in our webinars. We look forward to seeing you again in 2026!
youtu.be/P64PnU0WyZE?...
Thank you for your interest in our webinars. We look forward to seeing you again in 2026!
youtu.be/P64PnU0WyZE?...
Weihnachten 2025
YouTube video by MARKUS at HOMe
youtu.be
December 25, 2025 at 6:59 PM
The MARKUS@HOME editorial team wishes all colleagues a peaceful and blessed Christmas 2025.
Thank you for your interest in our webinars. We look forward to seeing you again in 2026!
youtu.be/P64PnU0WyZE?...
Thank you for your interest in our webinars. We look forward to seeing you again in 2026!
youtu.be/P64PnU0WyZE?...
Short-Term DOAC vs. DAPT for Preventing Device Thrombosis Following LAA-Closure: The ANDES RCT by Drs. Rodés-Cabau, Salaun et al.
www.ahajournals.org/doi/10.1161/...
The use of DOACs after LAAC failed to reduce DRT compared with DAPT, but it was associated with an improved safety profile.
www.ahajournals.org/doi/10.1161/...
The use of DOACs after LAAC failed to reduce DRT compared with DAPT, but it was associated with an improved safety profile.
December 23, 2025 at 7:29 PM
Short-Term DOAC vs. DAPT for Preventing Device Thrombosis Following LAA-Closure: The ANDES RCT by Drs. Rodés-Cabau, Salaun et al.
www.ahajournals.org/doi/10.1161/...
The use of DOACs after LAAC failed to reduce DRT compared with DAPT, but it was associated with an improved safety profile.
www.ahajournals.org/doi/10.1161/...
The use of DOACs after LAAC failed to reduce DRT compared with DAPT, but it was associated with an improved safety profile.
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes by Drs. Nicholls, D’Alessio et al.
www.nejm.org/doi/full/10....
Among patients with type 2 diabetes and atherosclerotic cardiovascular disease, tirzepatide was noninferior to dulaglutide.
www.nejm.org/doi/full/10....
Among patients with type 2 diabetes and atherosclerotic cardiovascular disease, tirzepatide was noninferior to dulaglutide.
December 18, 2025 at 7:33 PM
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes by Drs. Nicholls, D’Alessio et al.
www.nejm.org/doi/full/10....
Among patients with type 2 diabetes and atherosclerotic cardiovascular disease, tirzepatide was noninferior to dulaglutide.
www.nejm.org/doi/full/10....
Among patients with type 2 diabetes and atherosclerotic cardiovascular disease, tirzepatide was noninferior to dulaglutide.
Exercise and Kidney Health: Core Curriculum 2026 by Drs. Becerra, Mansour.
www.ajkd.org/article/S027...
This core curriculum reviews the physiology of exercise on kidney function and provides evidence-based strategies for patient counseling and risk reduction.
www.ajkd.org/article/S027...
This core curriculum reviews the physiology of exercise on kidney function and provides evidence-based strategies for patient counseling and risk reduction.
December 17, 2025 at 7:55 PM
Exercise and Kidney Health: Core Curriculum 2026 by Drs. Becerra, Mansour.
www.ajkd.org/article/S027...
This core curriculum reviews the physiology of exercise on kidney function and provides evidence-based strategies for patient counseling and risk reduction.
www.ajkd.org/article/S027...
This core curriculum reviews the physiology of exercise on kidney function and provides evidence-based strategies for patient counseling and risk reduction.
Pharmacologic Treatment of Heart Failure With Reduced Ejection Fraction: An Updated Systematic Review and Network Meta-Analysis by Drs. van Essen, Tromp et al.
www.jacc.org/doi/10.1016/...
www.jacc.org/doi/10.1016/...
Pharmacologic Treatment of Heart Failure With Reduced Ejection Fraction: An Updated Systematic Review and Network Meta-Analysis
Download article citation: If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
www.jacc.org
December 11, 2025 at 8:03 PM
Pharmacologic Treatment of Heart Failure With Reduced Ejection Fraction: An Updated Systematic Review and Network Meta-Analysis by Drs. van Essen, Tromp et al.
www.jacc.org/doi/10.1016/...
www.jacc.org/doi/10.1016/...
Tonight: Antithrombotic Therapy in ASCVD + VTE: AQUATIC - Prof. Behnood Bikdeli, Prof. Romain Didier
youtu.be/w8qCX2pRSxQ?...
@bbikdeli.bsky.social
youtu.be/w8qCX2pRSxQ?...
@bbikdeli.bsky.social
Antithrombotic Therapy in ASCVD + VTE: AQUATIC - Prof. Behnood Bikdeli, Prof. Romain Didier
YouTube video by MARKUS at HOMe
youtu.be
December 5, 2025 at 3:59 PM
Tonight: Antithrombotic Therapy in ASCVD + VTE: AQUATIC - Prof. Behnood Bikdeli, Prof. Romain Didier
youtu.be/w8qCX2pRSxQ?...
@bbikdeli.bsky.social
youtu.be/w8qCX2pRSxQ?...
@bbikdeli.bsky.social
VALIANT: Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN by Drs. Fakhouri, Nester et al.
www.nejm.org/doi/full/10....
Pegcetacoplan resulted in a significantly greater reduction in proteinuria than placebo among patients with C3 GN or primary immune-complex MPGN.
www.nejm.org/doi/full/10....
Pegcetacoplan resulted in a significantly greater reduction in proteinuria than placebo among patients with C3 GN or primary immune-complex MPGN.
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN | NEJM
C3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis (MPGN) generally result in glomerular C3 deposition and irreversible kidney damage. The efficacy and safety of ...
www.nejm.org
December 4, 2025 at 8:01 PM
VALIANT: Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN by Drs. Fakhouri, Nester et al.
www.nejm.org/doi/full/10....
Pegcetacoplan resulted in a significantly greater reduction in proteinuria than placebo among patients with C3 GN or primary immune-complex MPGN.
www.nejm.org/doi/full/10....
Pegcetacoplan resulted in a significantly greater reduction in proteinuria than placebo among patients with C3 GN or primary immune-complex MPGN.
Trends in CVE & Bleeding in Advanced CKD: SRR - Dr. M. Evans, Dr. A.-L. Faucon (Stockholm, Sweden)
youtu.be/S2hbWPWkzcU?...
youtu.be/S2hbWPWkzcU?...
Trends in CVE & Bleeding in Advanced CKD: SRR - Dr. M. Evans, Dr. A.-L. Faucon (Stockholm, Sweden)
YouTube video by MARKUS at HOMe
youtu.be
November 28, 2025 at 6:55 PM
Trends in CVE & Bleeding in Advanced CKD: SRR - Dr. M. Evans, Dr. A.-L. Faucon (Stockholm, Sweden)
youtu.be/S2hbWPWkzcU?...
youtu.be/S2hbWPWkzcU?...
High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease by Drs. Bartholdy, Biering-Sørensen et al.
www.jacc.org/doi/10.1016/...
In this prespecified analysis of DANFLU-2 a benefit of HD-IIV over SD-IIV was observed.
www.jacc.org/doi/10.1016/...
In this prespecified analysis of DANFLU-2 a benefit of HD-IIV over SD-IIV was observed.
November 27, 2025 at 8:33 PM
High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease by Drs. Bartholdy, Biering-Sørensen et al.
www.jacc.org/doi/10.1016/...
In this prespecified analysis of DANFLU-2 a benefit of HD-IIV over SD-IIV was observed.
www.jacc.org/doi/10.1016/...
In this prespecified analysis of DANFLU-2 a benefit of HD-IIV over SD-IIV was observed.
Extended DOAC Therapy in Provoked VTE - HI-PRO - Prof. Behnood Bikdeli, Prof. Romain Didier
@bbikdeli.bsky.social
youtu.be/e0Orc_Ps56U?...
@bbikdeli.bsky.social
youtu.be/e0Orc_Ps56U?...
Extended DOAC Therapy in Provoked VTE - HI-PRO - Prof. Behnood Bikdeli, Prof. Romain Didier
YouTube video by MARKUS at HOMe
youtu.be
November 21, 2025 at 7:39 PM
Extended DOAC Therapy in Provoked VTE - HI-PRO - Prof. Behnood Bikdeli, Prof. Romain Didier
@bbikdeli.bsky.social
youtu.be/e0Orc_Ps56U?...
@bbikdeli.bsky.social
youtu.be/e0Orc_Ps56U?...
Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD)
by Drs. Johansen, Biering-Sørensen et al.
www.thelancet.com/journals/lan...
In this analysis, HD-IIV demonstrated superior protection compared with SD-IIV.
by Drs. Johansen, Biering-Sørensen et al.
www.thelancet.com/journals/lan...
In this analysis, HD-IIV demonstrated superior protection compared with SD-IIV.
November 20, 2025 at 7:40 PM
Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD)
by Drs. Johansen, Biering-Sørensen et al.
www.thelancet.com/journals/lan...
In this analysis, HD-IIV demonstrated superior protection compared with SD-IIV.
by Drs. Johansen, Biering-Sørensen et al.
www.thelancet.com/journals/lan...
In this analysis, HD-IIV demonstrated superior protection compared with SD-IIV.
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects by Drs. Herrmann, Mitchell et al.
An International Cardio-Oncology Society Position Statement:
jamanetwork.com/journals/jam...
An International Cardio-Oncology Society Position Statement:
jamanetwork.com/journals/jam...
November 18, 2025 at 7:16 PM
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects by Drs. Herrmann, Mitchell et al.
An International Cardio-Oncology Society Position Statement:
jamanetwork.com/journals/jam...
An International Cardio-Oncology Society Position Statement:
jamanetwork.com/journals/jam...
Deferring Arterial Catheterization in Critically Ill Patients with Shock by Drs. Muller, Boulain et al.
www.nejm.org/doi/pdf/10.1...
Results for death from any cause at day 28 indicated that management without early arterial cath. insertion was noninferior to early cath. insertion.
www.nejm.org/doi/pdf/10.1...
Results for death from any cause at day 28 indicated that management without early arterial cath. insertion was noninferior to early cath. insertion.
November 16, 2025 at 5:40 PM
Deferring Arterial Catheterization in Critically Ill Patients with Shock by Drs. Muller, Boulain et al.
www.nejm.org/doi/pdf/10.1...
Results for death from any cause at day 28 indicated that management without early arterial cath. insertion was noninferior to early cath. insertion.
www.nejm.org/doi/pdf/10.1...
Results for death from any cause at day 28 indicated that management without early arterial cath. insertion was noninferior to early cath. insertion.